Latest Conference Articles

A genetic counselor discussed the various hereditary breast and ovarian cancer syndrome-associated cancers among men and how to manage them at the FORCE Annual Meeting.

Eva Moon, a writer, musician and performing artist, discusses her genetic mutation and how it changed the direction of her life.

Audra Moran, president and CEO of the Ovarian Cancer Research Fund Alliance, discusses the support available for caregivers of women with ovarian cancer.

Investigators are learning how to take a tumor biopsy from a patient, grow small tumors called organoids in the lab, and test cancer treatments on them to see which work best.

Thanks to targeted drugs and evolving research, women who experience recurrences of ovarian cancer have more treatment options than they did in the past..

Saketh Guntupalli, M.D., gynecologic oncologist at the University of Colorado Hospital, discusses ways that women can improve intimacy after an ovarian cancer diagnosis.

The first thing a woman should do after receiving a diagnosis of ovarian cancer, according to Teresa P. Díaz-Montes, M.D., M.P.H., is nothing. At least not right away.

New treatments are continually being explored as researchers use genetic testing and genomic sequencing to better understand characteristics of ovarian cancer that can be targeted with drugs.

The survey contained questions on a range of issues they may have experienced, including pain, fatigue, as well as issues with sexual function, body image and finances. Researchers then looked at the anxiety and depression associated with those issues, and talked with patients about what they thought might be causing those problems.

Using next-generation sequencing (NGS) to test patients with non-small cell lung cancer (NSCLC) for all known genetic mutations associated with the disease appeared to be faster and more cost-effective than testing for one gene at a time – not to mention the results could have treatment implications.

Patients who would otherwise not have access to genetic counseling at community-based medical centers can benefit from the use of remote phone or video technology to take advantage of these services, according to study results presented at the American Society of Clinical Oncology Annual Meeting in Chicago on June 1-4.

Insomnia is a common issue that many patients and survivors face. However, cognitive behavioral therapy and acupuncture was proven to be helpful in a recent study.

Sherry Pollex, founder of SherryStrong.com, offered women a variety of ways to lead a healthier lifestyle during treatment, and an array of hope to go through their journeys with joy and thanks.

Ryan Mitstifer is not like most 15-year-old boys. This weekend, while others may have been found hanging out with friends or catching up on schoolwork, Ryan is out spreading the word about ovarian cancer.

Stephanie V. Blank, M.D., talks about the MAGENTA study, designed to ease the time-consuming process for which women undergo genetic testing.

During the 2018 National Ovarian Cancer Coalition, Angeles Alvarez Secord, M.D., MHSc highlighted the importance of genetic testing and its impact on treatment options for women with ovarian cancer.

It is important that patients and their loved ones stay hopeful during the ovarian cancer journey. We asked attendees of the 2018 NOCC Annual Conference how they keep positive.

CURE sat down with Richard Boulay, M.D., at the 2018 National Ovarian Cancer Coalition to discuss exciting updates in ovarian cancer, as well as what advice he would offer to patients and caregivers who may be feeling overwhelmed.

Jaron Mark, M.D., a gynecologic oncology fellow at Roswell Park Comprehensive Cancer Center, discusses the opioid crisis, and the steps that his institution is taking to combat potential addiction in women who undergo surgery for gynecologic cancer.

PARP inhibitors are generating a lot of excitement in the field of ovarian cancer. But how, exactly, do they work? CURE spoke with one expert to find out.

Knowing which kind of therapy works best can help in determining the ideal cancer care for patients.

“There has been a rapid expansion in the use of checkpoint inhibition in many solid tumor types,” lead author Emily Hinchcliff, M.D.

At the inaugural Ovarian Cancer Heroes gala, held in New Orleans ahead of the 49th Society of Gynecologic Oncology Annual Meeting on Women’s Cancers, four individuals — a physician, nurse navigator and two patient-turned-advocates — were awarded for the contributions they have made to increase awareness and advance research and education for ovarian cancer.

Losing even a moderate amount of extra weight significantly reduces the risk of breast cancer for postmenopausal women, a researcher reports.

The incidence of human papillomavirus-related oropharyngeal cancer (HPV-OPC) is on the rise. Researchers at Johns Hopkins University assessed survey data to determine whether the risk among the general population is rising as well. Results show that for most people, the risk remains low.

Talazoparib, a PARP inhibitor is more effective than chemotherapy in reducing the risk of disease progression and death from BRCA-positive breast cancer.

Researchers find that women with postmenopausal hormone receptor (HR)-positive breast cancer may undergo shorter treatments of Arimidex, which may in turn cause less bone fractures.

A phase 3 clinical trial pitted a nine-week treatment of adjuvant Herceptin against the regimen of a full year of treatment for patients with HER2-positive breast cancer. Results show that the standard treatment of one year is still optimal.